17 research outputs found

    Neighbour-joining phylogeny of HIV-1 quasispecies based on <i>env</i> V1–V4.

    No full text
    <p>(A) Phylogeny of quasispecies isolated from Argentinean MSM and (B) Phylogeny of quasispecies isolated from Trinidadian heterosexuals. The sequences were isolated from samples collected soon after seroconversion. Percentage intrapatient diversity is presented for each patient and * highlights the patient who is infected by distantly related strains.</p

    Comparison of the median length and number of N-Linked Glycosylation Sites in the <i>Env</i> V2 and V3 of Subtype B HIV-1 from Trinidad and the Rest of the World (p-values represent comparison between recently transmitted HIV-1 from Trinidadian heterosexuals and others).

    No full text
    <p>ns =  not significant, </p><p>*bulk database sequences for two Argentinians within 3 months of seroconversion were included in the analyses,</p><p>**bulk database sequences <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0019995#pone.0019995-Nadai1" target="_blank">[2]</a>.</p

    Phylogeny of subtype B HIV-1 from Trinidad.

    No full text
    <p>Phylogeny was inferred using the neighbour-joining algorithm and is based on <i>env</i> V1-V4.</p

    Phylogenetic analysis of 14 nearly full genome sequences of HIV-1 Subtype B from Caribbean countries: Trinidad and Tobago (TT), Dominican Republic (DO), Haiti (HT) and Jamaica (JM).

    No full text
    <p>Reference subtype B sequences are indicated by the country of origin; they are: US: MN, JRCSF, SF2, WR27, P896, NY5, BCSG3C, YU2, RF, U23487; DE: D31, HAN; GB: CAM1, study sequences (bold) are identified by name. A neighbor-joining phylogenetic tree was built using the Kimura 2-parameter model and significant parsimony bootstrap values (>70%) were placed next to the nodes. The genetic distance corresponding to the lengths of the branches is shown by the scale below the tree.</p

    Number of vaccinations received.

    No full text
    <p>Abbreviations: NA – not applicable.</p><p>For vaccinations 1, 2 and 3, the denominator is the number of persons randomized to receive either 3 or 5 study injections.</p><p>For vaccinations 4 and 5, the denominator is the number randomized to 5 study injections.</p><p>The numerator is the number of people who actually received the specified vaccination.</p
    corecore